Company intelligence / Profile preview

KBI Biopharma

Durham, North Carolina, USAkbibiopharma.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

KBI Biopharma enables the advancement of over 160–170 drug candidates in preclinical/clinical stages and manufactures ten commercial products globally. The company is recognized for quality manufacturing services that help partners bring complex biologics to market efficiently.

Therapeutic areas: Other
Modalities: Monoclonal antibodies (mAbs)Bispecific antibodiesFc-fusion proteinsEnzymesPEGylated proteinsComplex glycoproteinsRecombinant proteinsCell therapies
Industry: Contract Manufacturing Organization

Partnerships

ReForm Biologics (formulation development)Alanis Therapeutics (CDMO partner for antibody program)

Beyond the preview

Go deeper on KBI Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KBI Biopharma.

Explore the full profile